Compile Data Set for Download or QSAR
Report error Found 92 of affinity data for UniProtKB/TrEMBL: Q01433
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM154583(6-[4-({[(1S)-1-(isoquinolin-8-yl)ethyl]amino}methy...)
Affinity DataIC50: 16nMpH: 7.4Assay Description:AMPD1 was added to buffer A (50 mM HEPES, 150 mM KCl, 5 mM MgCl2, and 0.5 mMglutathione [pH 7.4]) to a concentration of 10 nM. A substrate mix consis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/15/2015
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610224(CHEMBL5269095)
Affinity DataIC50: 30nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610231(CHEMBL5271711)
Affinity DataIC50: 60nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610244(CHEMBL5272816)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610242(CHEMBL5270167)
Affinity DataIC50: 110nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610243(CHEMBL5287644)
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610237(CHEMBL5287535)
Affinity DataIC50: 140nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610236(CHEMBL5276735)
Affinity DataIC50: 170nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610246(CHEMBL5281489)
Affinity DataIC50: 170nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610228(CHEMBL5284620)
Affinity DataIC50: 180nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610234(CHEMBL5289502)
Affinity DataIC50: 190nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610245(CHEMBL5281034)
Affinity DataIC50: 200nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610233(CHEMBL5271550)
Affinity DataIC50: 200nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610226(CHEMBL5266374)
Affinity DataIC50: 240nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610230(CHEMBL5283087)
Affinity DataIC50: 260nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610238(CHEMBL5284666)
Affinity DataIC50: 270nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610223(CHEMBL5280447)
Affinity DataIC50: 270nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610235(CHEMBL5277889)
Affinity DataIC50: 300nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087295(2-(2-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  300nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087332(2-Benzyl-6-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d...)
Affinity DataKi:  410nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610240(CHEMBL5280490)
Affinity DataIC50: 410nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610239(CHEMBL5282638)
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610227(CHEMBL5284646)
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610241(CHEMBL5290923)
Affinity DataIC50: 740nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087328(2-(3-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  790nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087304(2-(3-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  800nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087304(2-(3-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  800nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087331(6-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]dia...)
Affinity DataKi:  860nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087291(6-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]dia...)
Affinity DataKi:  920nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087321(2-[4-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]...)
Affinity DataKi:  970nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610224(CHEMBL5269095)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610225(CHEMBL5284837)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087296(2-(4-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  1.10E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610237(CHEMBL5287535)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087290(2-(3-Chloro-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-im...)
Affinity DataKi:  1.40E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610236(CHEMBL5276735)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610228(CHEMBL5284620)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610234(CHEMBL5289502)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087310(2-(4-Chloro-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-im...)
Affinity DataKi:  1.70E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610231(CHEMBL5271711)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610233(CHEMBL5271550)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610226(CHEMBL5266374)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087298(6-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]dia...)
Affinity DataKi:  2.10E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610229(CHEMBL5282210)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610235(CHEMBL5277889)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087329(2-(3-Bromo-phenyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  2.40E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610242(CHEMBL5270167)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Astrazeneca R&D

LigandPNGBDBM50087324(2-(3-Bromo-benzyl)-6-(8-hydroxy-7,8-dihydro-6H-imi...)
Affinity DataKi:  3.00E+3nMAssay Description:Evaluated for the inhibition of porcine heart or human L-type Adenosine 5'-monophosphate deaminase (AMPDA)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610239(CHEMBL5282638)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetAMP deaminase 2(Human)
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50610223(CHEMBL5280447)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of recombinant human AMPD2 using AMP as substrate incubated for 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
Displayed 1 to 50 (of 92 total ) | Next | Last >>
Jump to: